Effects of dietary curcumin in growth performance, oxidative status and gut morphometry and function of gilthead seabream postlarvae

An imbalance in the production and detoxification of reactive oxygen species and other oxidants can disrupt a l l types of cellular compounds, and lead to a state of oxidative stress. Preventing this state is essential to improve growth and health in animal production. Therefore, the aim of this work was to assess i f the dieta r y supple-mentation of curcumin cou l d improve the antioxidant status and intestine structu r e and functionalit y of gilthead seabream postlarvae, with the global objective of improving fish growth performance and robustness. Two experimental diets supplemented with different doses of curcumin (LOW and HIGH diets), and a commercial diet were fed to quadruplicate groups of postlarvae, for 20 days. At the end of the feeding trial fish fed the supple-mented diets significantly improved their antioxidant status compared to CTRL fed fish. LOW and HIGH fed fish presented lower protein oxidative damage (P 0.05). In conclusion, dieta r y curcumin supplementation was able to enhance gilthead seabream postlarvae robustness through a modulation of the oxidative status, increasing total antioxidant capacity and decreasing protein oxidative damage. This data pro-vide evidence that curcumin can be a suitable feed additive to promote heath status and robustness of fish at early stages of development, therefore contributing for the development and sustainabilit y of marine fish hatchery production.info:eu-repo/semantics/publishedVersio

19-base Pair Deletion Polymorphism Of The Dihydrofolate Reductase (dhfr) Gene: Maternal Risk Of Down Syndrome And Folate Metabolism [polimorfismo De Deleção De 19 Pares De Bases Do Gene Dihidrofolato Redutase (dhfr): Risco Materno Para Síndrome De Down E Metabolismo Do Folato]

Context and objective: Polymorphisms in genes involved in folate metabolism may modulate the maternal risk of Down syndrome (DS). This study evaluated the influence of a 19-base pair (bp) deletion polymorphism in intron-1 of the dihydrofolate reductase (DHFR) gene on the maternal risk of DS, and investigated the association between this polymorphism and variations in the concentrations of serum folate and plasma homocysteine (Hcy) and plasma methylmalonic acid (MMA). Design and setting: Analytical cross-sectional study carried out at Faculdade de Medicina de São José do Rio Preto (Famerp). Methods: 105 mothers of individuals with free trisomy of chromosome 21, and 184 control mothers were evaluated. Molecular analysis on the polymorphism was performed using the polymerase chain reaction (PCR) through differences in the sizes of fragments. Folate was quantified by means of chemiluminescence, and Hcy and MMA by means of liquid chromatography and sequential mass spectrometry. Results: There was no difference between the groups in relation to allele and genotype frequencies (P = 0.44; P = 0.69, respectively). The folate, Hcy and MMA concentrations did not differ significantly between the groups, in relation to genotypes (P > 0.05). Conclusions: The 19-bp deletion polymorphism of DHFR gene was not a maternal risk factor for DS and was not related to variations in the concentrations of serum folate and plasma Hcy and MMA in the study population.1284215218Freeman, S.B., Allen, E.G., Oxford-Wright, C.L., The National Down Syndrome Project: Design and implementation (2007) Public Health Rep, 122 (1), pp. 62-72Ramírez, N.J., Belalcázar, H.M., Yunis, J.J., Parental origin, nondisjunction, and recombination of the extra chromosome 21 in Down syndrome: A study in a sample of the Colombian population (2007) Biomedica, 27 (1), pp. 141-148James, S.J., Pogribna, M., Pogribny, I.P., Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome (1999) Am J Clin Nutr, 70 (4), pp. 495-501Patterson, D., Folate metabolism and the risk of Down syndrome (2008) Downs Syndr Res Pract, 12 (2), pp. 93-97Biselli, J.M., Goloni-Bertollo, E.M., Zampieri, B.L., Genetic polymorphisms involved in folate metabolism and elevated plasma concentrations of homocysteine: Maternal risk factors for Down syndrome in Brazil (2008) Genet Mol Res, 7 (1), pp. 33-42Meguid, N.A., Dardir, A.A., Khass, M., MTHFR genetic polymorphism as a risk factor in Egyptian mothers with Down syndrome children (2008) Dis Markers, 24 (1), pp. 19-26Coppedè, F., Migheli, F., Bargagna, S., Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring (2009) Neurosci Lett, 449 (1), pp. 15-19Pozzi, E., Vergani, P., Dalprà, L., Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome (2009) Am J Obstet Gynecol, 200 (6), pp. 636e1-636e6Stanislawska-Sachadyn, A., Brown, K.S., Mitchell, L.E., An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women (2008) Hum Genet, 123 (3), pp. 289-295Johnson, W.G., Stenroos, E.S., Spychala, J.R., New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): A risk factor for spina bifida acting in mothers during pregnancy? (2004) Am J Med Genet A, 124 A (4), pp. 339-345Parle-McDermott, A., Pangilinan, F., Mills, J.L., The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population (2007) Am J Med Genet A, 143 A (11), pp. 1174-1180Xu, X., Gammon, M.D., Wetmur, J.G., A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users (2007) Am J Clin Nutr, 85 (4), pp. 1098-1102Gellekink, H., Blom, H.J., van der Linden, I.J., den Heijer, M., Molecular genetic analysis of the human dihydrofolate reductase gene: Relation with plasma total homocysteine, serum and red blood cell folate levels (2007) Eur J Hum Genet, 15 (1), pp. 103-109Miller, S.A., Dykes, D.D., Polesky, H.F., A simple salting out procedure for extracting DNA from human nucleated cells (1988) Nucleic Acids Res, 16 (3), p. 1215Dulucq, S., St-Onge, G., Gagné, V., DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL (2008) Blood, 111 (7), pp. 3692-3700Haddad, R., Mendes, M.A., Höehr, N.F., Eberlin, M.N., Amino acid quantitation in aqueous matrices via trap and release membrane introduction mass spectrometry: Homocysteine in human plasma (2001) Analyst, 126 (8), pp. 1212-1215de Andrade, C.R., Fukada, S.Y., Olivon, V.C., Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia (2006) Eur J Pharmacol, 543 (1-3), pp. 83-91Carvalho, V.M., Kok, F., Determination of serum methylmalonic acid by alkylative extraction and liquid chromatography coupled to tandem mass spectrometry (2008) Anal Biochem, 381 (1), pp. 67-73Fenech, M., The role of folic acid and Vitamin B12 in genomic stability of human cells (2001) Mutat Res, 475 (1-2), pp. 57-67Wang, X., Thomas, P., Xue, J., Fenech, M., Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21 (2004) Mutat Res, 551 (1-2), pp. 167-180Beetstra, S., Thomas, P., Salisbury, C., Turner, J., Fenech, M., Folic acid deficiency increases chromosomal instability, chromosome 21 aneuploidy and sensitivity to radiation-induced micronuclei (2005) Mutat Res, 578 (1-2), pp. 317-326Finkelstein, J.D., Martin, J.J., Homocysteine (2000) Int J Biochem Cell Biol, 32 (4), pp. 385-389Coppedè, F., Marini, G., Bargagna, S., Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women (2006) Am J Med Genet A, 140 (10), pp. 1083-1091Wang, S.S., Qiao, F.Y., Feng, L., Lv, J.J., Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome in China (2008) J Zhejiang Univ Sci B, 9 (2), pp. 93-99Kalmbach, R.D., Choumenkovitch, S.F., Troen, A.P., A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate (2008) J Nutr, 138 (12), pp. 2323-2327van der Linden, I.J., Nguyen, U., Heil, S.G., Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida (2007) Mol Genet Metab, 91 (1), pp. 98-103Barkai, G., Arbuzova, S., Berkenstadt, M., Heifetz, S., Cuckle, H., Frequency of Down's syndrome and neural tube defects in the same family (2003) Lancet, 361 (9366), pp. 1331-1335Guéant, J.L., Guéant-Rodriguez, R.M., Anello, G., Genetic determinants of folate and vitamin B12 metabolism: A common pathway in neural tube defect and Down syndrome? (2003) Clin Chem Lab Med, 41 (11), pp. 1473-1477Klee, G.G., Cobalamin and folate evaluation: Measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate (2000) Clin Chem, 46 (8 PART 2), pp. 1277-1283Galloway, M., Rushworth, L., Red cell or serum folate? Results from the National Pathology Alliance benchmarking review (2003) J Clin Pathol, 56 (12), pp. 924-926Bunduki, V., Dommergues, M., Zittoun, J., Maternal-fetal folate status and neural tube defects: A case control study (1995) Biol Neonate, 67 (3), pp. 154-159Kilbride, J., Baker, T.G., Parapia, L.A., Khoury, S.A., Iron status, serum folate and B(12) values in pregnancy and postpartum: Report from a study in Jordan (2000) Ann Saudi Med, 20 (5-6), pp. 371-376Zhang, T., Xin, R., Gu, X., Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China (2009) Public Health Nutr, 12 (5), pp. 680-686Eser, B., Cosar, M., Eser, O., 677C>T and 1298A>C polymorphisms of methylenetetrahydropholate reductase gene and biochemical parameters in Turkish population with spina bifida occulta (2010) Turk Neurosurg, 20 (1), pp. 9-1